Xeris Biopharma (NASDAQ:XERS – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Friday, November 8th. Analysts expect the company to announce earnings of ...

The effects of such corrections have been studied only in adults.(5 5 Hamill RJ, Robinson LM, Wexler HR, Moote C. Efficacy and safety of potassium infusion therapy in hypokalemic critically ill ...

Disorders which may lead to hypokalemia like Gitelman syndrome, Bartter syndrome, Andersen-Tawil syndrome, renal tubular acidosis or periodic hypokalemic paralysis were excluded by the negative ...